
The company aims to provide one billion women with access to better screening globally

The technology could help surgeons identify and remove cancerous tissue more accurately

Gabbi will launch in 2023, giving women access to risk assessment results and personalised care plans

The trial is estimated to be completed by the end of 2023

Breast cancer is the most diagnosed cancer in the UK and the second most common cause of cancer mortality in women

Each year about 264,000 cases of women in the US are diagnosed with breast cancer

Ireland's Women’s Health Fund aims to drive research, innovation and support for women in at-risk populations

The government-led strategy aims to increase understanding of female-specific health conditions and tackle data gaps

By Afua Basoah, Head of Health Strategy for RAPP UK

Femtech World meets the Swiss company on a mission to enable optimal breast cancer treatment and make lasting metastasis prevention a reality. Breast cancer is the...